Tag: MILD
MCI, Dementia Risks Up With Increasing Biological Severity of Alzheimer Disease
Monotonic increase in lifetime risk of MCI, dementia seen with increasing amyloid PET centiloid value among those who were currently cognitively unimpaired
AHA: Optimal Heart Health Linked to Reduced MCI Risk in Type 2 Diabetes
Lower risk for MCI and dementia also seen with moderate, high cardiovascular health in those with high polygenic risk score
Intranasal Insulin, Empagliflozin Have Promising Effects on Cognition
Intranasal insulin increased mPACC-5, modulated fractional anisotropy and cerebral blood flow
Insomnia Linked to Cognitive Decline, Cognitive Impairment
Insomnia linked to faster decline in global cognition scores and increased risk for cognitive impairment in older adults
Alzheimer Disease Associated With Greater Neural Flexibility
Neural flexibility also predicts dementia transition
Intranasal Administration of PET Radiotracer Delivers Insulin to Multiple Brain Regions
Elevated standard uptake values were seen for 11 brain regions, including regions that support cognition
Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI
Further increase in risk was seen with prescription frequency, with higher risk for 12 or more prescriptions
Triglyceride-Glucose Index May Predict Faster Cognitive Decline in Early Phases of Alzheimer Disease
High triglyceride-glucose index significantly associated with faster cognitive decline in the MCI-Alzheimer disease subgroup
